107 related articles for article (PubMed ID: 30158361)
61. Relationship between nutritional profile, measures of adiposity, and bone mineral density in postmenopausal Saudi women.
Alissa EM; Alnahdi WA; Alama N; Ferns GA
J Am Coll Nutr; 2014; 33(3):206-14. PubMed ID: 24869980
[TBL] [Abstract][Full Text] [Related]
62. The effect of vitamin D receptor BsmI genotype on the response to osteoporosis treatment in postmenopausal women: a pilot study.
Creatsa M; Pliatsika P; Kaparos G; Antoniou A; Armeni E; Tsakonas E; Panoulis C; Alexandrou A; Dimitraki E; Christodoulakos G; Lambrinoudaki I
J Obstet Gynaecol Res; 2011 Oct; 37(10):1415-22. PubMed ID: 21651652
[TBL] [Abstract][Full Text] [Related]
63. Bone Mineral Density in Sheehan's Syndrome; Prevalence of Low Bone Mass and Associated Factors.
Chihaoui M; Yazidi M; Chaker F; Belouidhnine M; Kanoun F; Lamine F; Ftouhi B; Sahli H; Slimane H
J Clin Densitom; 2016 Oct; 19(4):413-418. PubMed ID: 26993664
[TBL] [Abstract][Full Text] [Related]
64. The relationship between the metabolic syndrome and its components and bone status in postmenopausal women.
Fodor D; Vesa S; Albu A; Simon S; Craciun A; Muntean L
Acta Physiol Hung; 2014 Jun; 101(2):216-27. PubMed ID: 24901081
[TBL] [Abstract][Full Text] [Related]
65. Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.
Powles TJ; Hickish T; Kanis JA; Tidy A; Ashley S
J Clin Oncol; 1996 Jan; 14(1):78-84. PubMed ID: 8558225
[TBL] [Abstract][Full Text] [Related]
66. Solitary nodular disease and multinodular goiter: a retrospective study on suppressive versus replacement levothyroxine therapy.
Paggi A; Persegani-Trimarchi C; Russo P; Mastropasqua M; Mosetti MA; Losi T; Leri O
Endocr Res; 1999 May; 25(2):229-38. PubMed ID: 10382684
[TBL] [Abstract][Full Text] [Related]
67. Possible limited bone loss with suppressive thyroxine therapy is unlikely to have clinical relevance.
Müller CG; Bayley TA; Harrison JE; Tsang R
Thyroid; 1995 Apr; 5(2):81-7. PubMed ID: 7647577
[TBL] [Abstract][Full Text] [Related]
68. Influence of thyroid hormones on bone density.
Begić A; Begić A; Arnautović-Halimić A
Med Glas (Zenica); 2020 Feb; 17(1):35-40. PubMed ID: 31663319
[TBL] [Abstract][Full Text] [Related]
69. Short term effects of levothyroxine treatment in thyroid multinodular disease.
Cesareo R; Iozzino M; Isgrò MA; Annunziata F; Di Stasio E
Endocr J; 2010; 57(9):803-9. PubMed ID: 20683172
[TBL] [Abstract][Full Text] [Related]
70. Modeling the effect of levothyroxine therapy on bone mass density in postmenopausal women: a different approach leads to new inference.
Mohammadi B; Haghpanah V; Tavangar SM; Larijani B
Theor Biol Med Model; 2007 Jun; 4():23. PubMed ID: 17559682
[TBL] [Abstract][Full Text] [Related]
71. The effect of long-term oestradiol implantation on bone mineral density in postmenopausal women who have undergone hysterectomy and bilateral oophorectomy.
Wahab M; Ballard P; Purdie DW; Cooper A; Willson JC
Br J Obstet Gynaecol; 1997 Jun; 104(6):728-31. PubMed ID: 9197878
[TBL] [Abstract][Full Text] [Related]
72. Low bone turnover and increase of bone mineral density in a premenopausal woman with postoperative hypoparathyroidism and thyroxine suppressive therapy.
Amrein K; Dimai HP; Dobnig H; Fahrleitner-Pammer A
Osteoporos Int; 2011 Nov; 22(11):2903-5. PubMed ID: 20959964
[TBL] [Abstract][Full Text] [Related]
73. Bone mineral density in well-differentiated thyroid cancer patients treated with suppressive thyroxine: a systematic overview of the literature.
Quan ML; Pasieka JL; Rorstad O
J Surg Oncol; 2002 Jan; 79(1):62-9; discussion 69-70. PubMed ID: 11754378
[TBL] [Abstract][Full Text] [Related]
74. Nodular goiter--is thyroxine medication of any value?
Persson CP; Johansson H; Westermark K; Karlsson FA
World J Surg; 1982 Jul; 6(4):391-6. PubMed ID: 6812295
[No Abstract] [Full Text] [Related]
75. Effect of thyrotropin suppressive therapy on lumbar bone mineral density in patients with differentiated thyroid cancer: a retrospective cohort study.
Wang X; Teng R; Liu F; Liu P; Yang Y
Gland Surg; 2022 Feb; 11(2):432-441. PubMed ID: 35284311
[TBL] [Abstract][Full Text] [Related]
76. Nodular goiter: effects of surgery and thyroxine medication.
Westermark K; Persson CP; Johansson H; Karlsson FA
World J Surg; 1986 Jun; 10(3):481-7. PubMed ID: 3088852
[No Abstract] [Full Text] [Related]
77. Letter to the Editor: "Evaluation of Bone Mineral Density Using DXA and cQCT in Postmenopausal Patients Under Thyrotropin Suppressive Therapy".
Tournis S; Trovas G; Triantafyllopoulos IK; Balanika AP
J Clin Endocrinol Metab; 2019 Apr; 104(4):1345-1346. PubMed ID: 30260408
[No Abstract] [Full Text] [Related]
78. Reply to Letter to the Editor: "Evaluation of Bone Mineral Density Using DXA and cQCT in Postmenopausal Patients Under Thyrotropin Suppressive Therapy".
Jeon YK; Kim IJ; Kim K
J Clin Endocrinol Metab; 2019 Apr; 104(4):1347. PubMed ID: 30260392
[No Abstract] [Full Text] [Related]
79. [Euthyroid struma with a thyroid nodule. Is the combination of L-thyroxine and iodine effective here?].
Füessl HS; Stiefelhagen P
MMW Fortschr Med; 2014 Apr; 156(8):17. PubMed ID: 24851428
[No Abstract] [Full Text] [Related]
80. Pharmacotherapy for thyroid nodules. A systematic review and meta-analysis.
Richter B; Neises G; Clar C
Endocrinol Metab Clin North Am; 2002 Sep; 31(3):699-722. PubMed ID: 12227128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
